Laura King

Publications (9)65.06 Total impact

• Article: Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.

  Michael B Atkins, Ronald M Bukowski, Bernard J Escudier, Robert A Figlin, Gary H Hudes, William G Kaelin, W Marston Linehan, David F McDermott, James W Mier, Ivan Pedrosa, Brian I Rini, Sabina Signoretti, Jeffrey A Sosman, Bin Tean Teh, Christopher G Wood, Amado J Zurita, Laura King
  [show abstract] [hide abstract]
  ABSTRACT: The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.
  Cancer 05/2009; 115(10 Suppl):2247-51. · 4.77 Impact Factor
• Article: Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference

  Michael B. Atkins MD, Ronald M. Bukowski MD, Bernard J. Escudier MD, Robert A. Figlin MD, Gary H. Hudes MD, William G. Kaelin Jr MD, W. Marston Linehan MD, David F. McDermott MD, James W. Mier MD, Ivan Pedrosa MD, Brian I. Rini MD, Sabina Signoretti MD, Jeffrey A. Sosman MD, Bin Tean Teh MD, Christopher G. Wood MD, Amado J. Zurita MD, Laura King
  [show abstract] [hide abstract]
  ABSTRACT: The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow. Cancer 2009;115(10 suppl):2247-51. © 2009 American Cancer Society.
  Cancer 04/2009; 115(S10):2247 - 2251. · 4.77 Impact Factor
• Source

  Available from: Towia Libermann

  Article: Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.

  Michael B Atkins, Marc S Ernstoff, Robert A Figlin, Keith T Flaherty, Daniel J George, William G Kaelin, Eugene D Kwon, Towia A Libermann, W Marston Linehan, David F McDermott, Augusto C Ochoa, Allan J Pantuck, Brian I Rini, Mark A Rosen, Jeffrey A Sosman, Vikas P Sukhatme, Johannes W Vieweg, Christopher G Wood, Laura King
  [show abstract] [hide abstract]
  ABSTRACT: Innovations and Challenges in Renal Cancer, chaired by Michael B. Atkins, was held April 28 to 29, 2006 in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, urology, immunology, radiology, and immunotherapy, with the goal of advancing the field of renal cancer treatment by critiquing new data from ongoing clinical trials and stimulating communication among those involved in basic and clinical research. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on important aspects of renal cancer genetics and biology and advances in prognostic classification and treatment.
  Clinical Cancer Research 02/2007; 13(2 Pt 2):667s-670s. · 7.74 Impact Factor
• Article: Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference.

  Allan Lipton, James R Berenson, Jean-Jacques Body, Brendan F Boyce, Oyvind S Bruland, Michael A Carducci, Charles S Cleeland, Denis R Clohisy, Robert E Coleman, Richard J Cook, Theresa A Guise, Roger N Pearse, Trevor J Powles, Michael J Rogers, G David Roodman, Matthew R Smith, Larry J Suva, Robert L Vessella, Katherine N Weilbaecher, Laura King
  [show abstract] [hide abstract]
  ABSTRACT: The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss. The conference format combined brief presentations with extended periods of discussion. The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings.
  Clinical Cancer Research 11/2006; 12(20 Pt 2):6209s-6212s. · 7.74 Impact Factor
• Source

  Available from: informedicalcme.com

  Article: Innovations and challenges in melanoma: summary statement from the first Cambridge conference.

  Michael B Atkins, David E Elder, Richard Essner, Keith T Flaherty, Thomas F Gajewski, Frank G Haluska, Patrick Hwu, Ulrich Keilholz, John M Kirkwood, James W Mier, Merrick I Ross, Craig L Slingluff, Vernon K Sondak, Jeffrey A Sosman, Martin A Weinstock, Laura King
  [show abstract] [hide abstract]
  ABSTRACT: Innovations and Challenges in Melanoma, chaired by Michael Atkins and cochaired by Ulrich Keilholz, John Kirkwood, and Jeffrey Sosman, was held July 15 to 16, 2005, in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, surgical oncology, anatomic pathology, dermatology, and immunotherapy who wished to advance the field of melanoma treatment by exchanging information and perspectives regarding recent advances and recommendations for further study. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on how genetics, biology, and data information can enhance our understanding of melanoma biology and help inform the use of therapies for this disease.
  Clinical Cancer Research 05/2006; 12(7 Pt 2):2291s-2296s. · 7.74 Impact Factor
• Article: Innovations and challenges in renal cancer: consensus statement from the first international conference.

  Michael B Atkins, David E Avigan, Ronald M Bukowski, Richard W Childs, Janice P Dutcher, Tim G Eisen, Robert A Figlin, James H Finke, Robert C Flanigan, Daniel J George, [......], Othon Iliopoulos, William G Kaelin, W Marston Linehan, Allan Lipton, Robert J Motzer, Andrew C Novick, Walter M Stadler, Bin Tean Teh, James C Yang, Laura King
  Clinical Cancer Research 10/2004; 10(18 Pt 2):6277S-81S. · 7.74 Impact Factor
• Article: Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response.

  Ajay Nehra, William D Steers, Stanley E Althof, Karl-Erik Andersson, Arthur Louis Burnett, Raymond A Costabile, Irwin Goldstein, Robert A Kloner, Tom F Lue, Alvaro Morales, Raymond C Rosen, Ridwan Shabsigh, Mike B Siroky, Laura King
  The Journal of Urology 09/2003; 170(2 Pt 2):S3-5. · 3.75 Impact Factor
• Article: Progress in the management of gynecologic cancer: consensus summary statement.

  Stephen A Cannistra, Robert C Bast, Jonathan S Berek, Michael A Bookman, Christopher P Crum, Paul D DePriest, Judy E Garber, Wui-Jin Koh, Maurie Markman, William P McGuire, Peter G Rose, Eric K Rowinsky, Gordon J S Rustin, Steven J Skates, Paul A Vasey, Laura King
  Journal of Clinical Oncology 06/2003; 21(10 Suppl):129s-132s. · 18.37 Impact Factor
• Article: Overview consensus statement.

  David R Staskin, Alan J Wein, Karl Erik Andersson, Stuart B Bauer, Jerry G Blaivas, Kathryn L Burgio, Linda Cardozo, Christopher R Chapple, Roger R Dmochowski, Suneel Gupta, Jacek L Mostwin, Joseph G Ouslander, Jeffrey P Weiss, Laura King
  Urology 12/2002; 60(5 Suppl 1):1-6. · 2.43 Impact Factor